162 related articles for article (PubMed ID: 36461610)
1. Multitargeted C9-substituted ester and ether derivatives of berberrubine for Alzheimer's disease: Design, synthesis, biological evaluation, metabolic stability, and pharmacokinetics.
Raghuvanshi R; Jamwal A; Nandi U; Bharate SB
Drug Dev Res; 2023 Feb; 84(1):121-140. PubMed ID: 36461610
[TBL] [Abstract][Full Text] [Related]
2. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
Nuthakki VK; Yadav Bheemanaboina RR; Bharate SB
Bioorg Chem; 2021 Feb; 107():104568. PubMed ID: 33418314
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Pharmacological Evaluation of Embelin-Aryl/alkyl Amine Hybrids as Orally Bioavailable Blood-Brain Barrier Permeable Multitargeted Agents with Therapeutic Potential in Alzheimer's Disease: Discovery of SB-1448.
Nuthakki VK; Choudhary S; Reddy CN; Bhatt S; Jamwal A; Jotshi A; Raghuvanshi R; Sharma A; Thakur S; Jadhav HR; Bharate SS; Nandi U; Kumar A; Bharate SB
ACS Chem Neurosci; 2023 Mar; 14(6):1193-1219. PubMed ID: 36812360
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
[TBL] [Abstract][Full Text] [Related]
5. Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent.
Nuthakki VK; Sharma A; Kumar A; Bharate SB
Drug Dev Res; 2019 Aug; 80(5):655-665. PubMed ID: 31050027
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors.
Nuthakki VK; Mudududdla R; Sharma A; Kumar A; Bharate SB
Bioorg Chem; 2019 Sep; 90():103062. PubMed ID: 31220673
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease.
Choubey PK; Tripathi A; Sharma P; Shrivastava SK
Bioorg Med Chem; 2020 Nov; 28(22):115721. PubMed ID: 33007563
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents.
Panek D; Więckowska A; Pasieka A; Godyń J; Jończyk J; Bajda M; Knez D; Gobec S; Malawska B
Molecules; 2018 Feb; 23(2):. PubMed ID: 29414887
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and structure-activity relationship of caffeine-based triazoles as dual AChE and BACE-1 inhibitors.
Sharma M; Sharma A; Nuthakki VK; Bhatt S; Nandi U; Bharate SB
Drug Dev Res; 2022 Dec; 83(8):1803-1821. PubMed ID: 36161804
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
Jannat S; Balupuri A; Ali MY; Hong SS; Choi CW; Choi YH; Ku JM; Kim WJ; Leem JY; Kim JE; Shrestha AC; Ham HN; Lee KH; Kim DM; Kang NS; Park GH
Exp Mol Med; 2019 Feb; 51(2):1-18. PubMed ID: 30755593
[TBL] [Abstract][Full Text] [Related]
11. A Coumarin-Donepezil Hybrid as a Blood-Brain Barrier Permeable Dual Cholinesterase Inhibitor: Isolation, Synthetic Modifications, and Biological Evaluation of Natural Coumarins.
Sharma A; Nuthakki VK; Gairola S; Singh B; Bharate SB
ChemMedChem; 2022 Sep; 17(18):e202200300. PubMed ID: 35892288
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors.
Kilic B; Erdogan M; Gulcan HO; Aksakal F; Oruklu N; Bagriacik EU; Dogruer DS
Med Chem; 2019; 15(1):59-76. PubMed ID: 29792155
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy.
Verma A; Waiker DK; Singh N; Roy A; Singh N; Saraf P; Bhardwaj B; Krishnamurthy S; Trigun SK; Shrivastava SK
ACS Chem Neurosci; 2024 Feb; 15(4):745-771. PubMed ID: 38327209
[TBL] [Abstract][Full Text] [Related]
16. New Pyrimidine and Pyridine Derivatives as Multitarget Cholinesterase Inhibitors: Design, Synthesis, and
Bortolami M; Pandolfi F; Tudino V; Messore A; Madia VN; De Vita D; Di Santo R; Costi R; Romeo I; Alcaro S; Colone M; Stringaro A; Espargaró A; Sabatè R; Scipione L
ACS Chem Neurosci; 2021 Nov; 12(21):4090-4112. PubMed ID: 34652128
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Shan WJ; Huang L; Zhou Q; Meng FC; Li XS
Eur J Med Chem; 2011 Dec; 46(12):5885-93. PubMed ID: 22019228
[TBL] [Abstract][Full Text] [Related]
18. Cyanobiphenyls: Novel H
Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M
Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of Piperazine and
Waiker DK; Verma A; Akhilesh ; A GT; Singh N; Roy A; Dilnashin H; Tiwari V; Trigun SK; Singh SP; Krishnamurthy S; Lama P; Davisson VJ; Shrivastava SK
ACS Chem Neurosci; 2023 Jun; 14(11):2217-2242. PubMed ID: 37216500
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents.
Panek D; Więckowska A; Jończyk J; Godyń J; Bajda M; Wichur T; Pasieka A; Knez D; Pišlar A; Korabecny J; Soukup O; Sepsova V; Sabaté R; Kos J; Gobec S; Malawska B
ACS Chem Neurosci; 2018 May; 9(5):1074-1094. PubMed ID: 29345897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
